Skip to main content

Table 1 Participant characteristics

From: Metabolic syndrome and inflammatory biomarkers: a community-based cross-sectional study at the Framingham Heart Study

  Metabolic Syndrome
  No (n = 1586) Yes (n = 984)
Age, years 58 ± 9 62 ± 9
Women, % 60 52
Body mass index, kg/m2 25.9 ± 4.2 30.5 ± 5.0
Mean waist, cm 93 ± 12 106 ± 11
Systolic blood pressure, mmHg 120 ± 17 133 ± 18
   22 64
Hypertension treatment, % 15 44
   14 11
Triglycerides, mg/dl 101 ± 53 171 ± 91
Total/HDL cholesterol 3.5 ± 1.0 4.6 ± 1.3
Lipid treatment, % 5 27
Aspirin use, % 22 29
Hormone replacement therapy, % 20 16
Metabolic syndrome components, % (n)
Elevated waist circumference ≥102 cm in men, ≥88 cm in women 41 (655) 88 (862)
Elevated triglycerides ≥150 mg/dL 16 (248) 69 (679)
Low HDL <40 mg/dL in men, <50 mg/dL in women 11 (169) 53 (522)
High blood pressure Systolic BP ≥130, diastolic BP ≥85 mmHg or treatment 32 (502) 79 (778)
Hyperglycemia Fasting glucose ≥100 and <126 mg/dL 17 (273) 67 (661)
  1. Data are mean ± standard deviation and % (n). BP denotes blood pressure.